Syros Pharmaceuticals Cash from Investing (TTM) Trends

Syros Pharmaceuticals Inc (SYRS)

5.13 -0.07 (-1.35%) USD | NASDAQ | May 03, 16:00

5.13 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	37.34M
September 30, 2023	73.54M
June 30, 2023	51.09M
March 31, 2023	34.05M
December 31, 2022	67.18M
September 30, 2022	29.22M
June 30, 2022	5.726M
March 31, 2022	-45.01M
December 31, 2021	-52.65M
September 30, 2021	-52.44M
June 30, 2021	-35.66M
March 31, 2021	3.199M
December 31, 2020	46.66M
September 30, 2020	63.65M
June 30, 2020	7.028M
March 31, 2020	35.70M
December 31, 2019	-11.73M

Date	Value
September 30, 2019	-8.65M
June 30, 2019	-12.04M
March 31, 2019	-27.23M
December 31, 2018	-10.64M
September 30, 2018	-30.75M
June 30, 2018	1.958M
March 31, 2018	-5.332M
December 31, 2017	-15.59M
September 30, 2017	-40.86M
June 30, 2017	-13.22M
March 31, 2017	-23.71M
December 31, 2016	-27.34M
September 30, 2016	-2.301M
June 30, 2016	-2.832M
March 31, 2016	-2.593M
December 31, 2015	-1.176M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-52.65M

Minimum

Dec 2021

73.54M

Maximum

Sep 2023

12.43M

Average

7.028M

Median

Jun 2020

Cash from Investing (TTM) Benchmarks